What’s wrong with this company? I mean, despite such good financials, why there is so little institutional or expert interest in RPG Lifesciences? Is it just because of absence of USFDA or focus on acute therapies or I am missing something else?
(Disc: Tracking, no positions)
| Subscribe To Our Free Newsletter |
